Latest Updates
-
Instead Of Impossible New Year Resolutions, Try These Smarter Alternatives In 2026 -
Countdown To 2026: Top 6 Indian Destinations For Stunning New Year’s Eve Fireworks -
Gold Rate In India Today Falls for 3rd Straight Day Ahead of New Year 2026; 24K, 22K 18K Now Off Record High On Decemeber 31 -
2026 Long Weekend Calendar: Plan Your Leaves For The New Year Before Everyone Else -
New Year Resolution: Morning Routine for a Healthy 2026; What to Eat, Drink & Avoid -
Kurma Dwadashi 2025 On December 31st: Vishnu’s Kurma Vrat And Its Year-End Significance -
New Year 2026: 7 Habits That Will Improve Your Health, Mind and Soul -
Daily Horoscope, Dec 31, 2025: Libra to Pisces; Astrological Prediction for all Zodiac Signs -
The Fertility Fear Loop: Expert Explains How Social Pressure Affects Women’s Reproductive Health -
Your PAN Card May Stop Working From December 31, What Every Taxpayer Must Know
Meftal-Spas Tablet: Why Govt Has Issued Safety Alert Against This Popular Painkiller For Menstrual Cramps
Meftal Spas is an anti-inflammatory and non-steroidal drug manufactured by Blue Cross Laboratories Pvt. Ltd. It is available in tablet form and cannot be bought over the counter without a bona fide prescription. Meftal Spas composition includes two active salts namely dicyclomine hydrochloride and mefenamic acid in 1:25 ratio.
Meftal,
a
painkiller
popularly
used
to
treat
menstrual
cramps,
has
come
under
the
radar
as
the
Indian
Pharmacopoeia
Commission
(IPC)
has
issued
a
drug
safety
alert
for
Mefenamic
acid.
The
IPC
has
urged
consumers
and
healthcare
professionals
to
remain
vigilant
regarding
potential
adverse
drug
reactions
(ADRs)
linked
to
the
drug.
The
alert
stems
from
a
preliminary
analysis
of
adverse
drug
reactions
reported
in
the
Pharmacovigilance
Programme
of
India
(PvPI)
database,
revealing
instances
of
Drug
Rash
with
Eosinophilia
and
Systemic
Symptoms
(DRESS)
syndrome.

DRESS
Syndrome
DRESS
syndrome,
a
severe
allergic
reaction
affecting
approximately
10%
of
individuals,
poses
potential
life-threatening
risks
and
is
associated
with
specific
medications.
It
comes
as
fever,
skin
rash,
lymphadenopathy,
hematological
abnormalities,
and
internal
organ
involvement,
typically
surfacing
two
to
eight
weeks
after
the
drug
has
been
taken.
Side
Effects
Studies
suggest
a
correlation
between
the
use
of
nonsteroidal
anti-inflammatory
drugs
(NSAIDs),
including
mefenamic
acid,
and
an
increased
risk
of
cardiovascular
events,
particularly
in
individuals
with
pre-existing
heart
conditions.
In
addition
to
the
intended
effects,
consumption
of
meftal
spas
may
also
cause
side
effects
in
some
people
.
These
side
effects
end
once
the
course
of
treatment
is
completed.
However,
if
any
symptoms
are
observed,
immediate
medical
attention
should
be
obtained.
The
following
side
effects
can
be
observed:
Abdominal
pain
Indigestion
Dry
mouth
Blurred
vision
Increased
blood
pressure
Swelling
and
skin
rash,
for
example,
Urticaria
and
Edema
Acidity
and
Gastritis
Vomiting
and
nausea
Itching
and
increased
sweating
Precaution:
Pregnancy-
Meftal
Spas
should
not
be
taken
during
pregnancy
as
it
can
cause
abnormalities
in
the
growing
foetus.
It
can
also
delay
labor
and
can
increase
bleeding
tendency
in
both
mother
and
child.
Kidney
disease-
In
patients
with
kidney
disease,
this
tablet
should
be
used
with
caution.
Tablet
dosage
can
need
to
be
adjusted.
Patients
with
end-stage
kidney
disease
should
avoid
taking
this
tablet.
Liver-
Meftal
is
also
not
appropriate
for
liver
patients
and
should
be
taken
as
per
doctor's
advice.



Click it and Unblock the Notifications











